Category: UN/WHO

Posted on

UofT/DLSPH “Centre For Vaccine Preventable Diseases” Was Prelude To Ontario Science Table

On May 9, 2019, the University of Toronto announced the creation of the “Centre for Vaccine Preventable Diseases”.

It seems that the groundwork for the Ontario Science Table (OST) was laid out months before this “pandemic” hit. It came when the Center for Vaccine Preventable Diseases was launched.

The OST is already a questionable organization given: (a) rampant ties the the University of Toronto; (b) conflicts of interest with its partners and members; (c) the brainchild of PHAC works for them; and (d) the former research chief of the Ontario UBI pilot project works for them.

Ontario Deputy Medical Officer, Barbara Yaffe, is worth a long hard look. She has climbed the ranks and gained power, despite never practicing as a doctor. Another one is Michael Warner, who financially benefits from prolonged lockdowns. It’s also disturbing that NSERC/CIHR are actually paying people to act as vaccine salesmen, and cloak it as research.

The centre will draw on strengths across many disciplines of U of T and its key partners in Toronto, including Public Health Ontario, ICES and Toronto Public Health, and globally including the World Health Organization and Gavi, a vaccine alliance. It will bring together experts from public health, medicine, pharmacy, nursing, social work, chemistry and the social sciences, along with bioethicists and biostatisticians, to turn the tide on vaccine rates in Ontario and around the globe.

“Vaccine hesitancy is a highly complex problem because it mirrors the public’s historically low trust in institutions and experts overall,” says Natasha Crowcroft, the centre’s director and a professor at Dalla Lana School and the Faculty of Medicine’s department of laboratory medicine and pathobiology who is also chief science officer at Public Health Ontario and adjunct scientist at ICES.

“With the return of diseases once thought to be eradicated in many countries, we need a much wider group of experts around the table.”

Anti-vaccine beliefs are growing just as the immunization field is expanding, with new technologies and target diseases, and improved opportunities to save lives around the globe. With this progress, gaps in our understanding of basic biological and immunological mechanisms are rapidly emerging. The centre will help to fill these knowledge gaps through interdisciplinary collaboration.

Very interesting that the World Health Organization and GAVI (Global Alliance for Vaccines and Immunizations) are partners with the University of Toronto. Surely, that won’t lead to any problems down the road.

Bit of a side note: Jeff Kwong, Interim Director of CVPD co-authored a piece with Bonnie Henry in 2017 on mandatory vaccinate or mask policies in B.C. health care facilities.

Kwong has been a vocal shill for WHO/UofT talking points. Chief among them, that vaccines are perfectly safe, and only a fringe group of “anti-vaxxers” would oppose such measures. He uncritically supports the official narrative, which makes him perfect for the role.

The Globe & Mail covered the story originally, but apparently has picked up on nothing out of the ordinary coming in the months since.

On November 13, 2019, the CVPD held a seminar regarding working with the WHO. This differed considerably in tone from Event 201, which was a simulated disaster.

Join the Centre for Vaccine Preventable Diseases for a panel discussion on What it Means to be an International Expert for the World Health Organization. The discussion will focus on improving understanding of:

-The role of immunization experts with global agencies like the World Health Organization, and how this differs from expert roles within national organizations
-The contribution of Canadians to global policy on immunization.

Did no one think it strange that the biggest vaccination effort in human history would start just months after this conference? In all seriousness, this should alarm people. Right now, the University of Toronto is simultaneously connected to:

  • Increasing vaccine uptake
  • Modelling for Covid-19 cases/deaths
  • Advising Doug Ford on restricting the rights of Ontario
  • Several Medical Officers of Health work here

Some of the same people whose job it was to get more people vaccinated (with the Centre for Vaccine Preventable Diseases) are now in a position to more or less impose that mandate (with the Ontario Science Table).

Vinita Dubey is part of the CVPD, and is part of the Behavioural Science Working Group. She is also an Associate Medical Officer of Health for Toronto at the same time. She reports to Eileen De Villa, another UofT Professor, who is very lockdown happy.

Jennie Johnstone was named to the CVPD, and is now part of the Congregate Care Setting Working Group with the OST.

Allison McGeer is part of the CVPD, and later joined the OST, but doesn’t appear to be part of any working group.

David McKeown and Fiona Kouyoumdjian get an honourable mention. They part of the Behavioural Science Working Group at OST, while being Associate Medical Officers of Health for Ontario, working with David Williams and Barbara Yaffe.

And as shown in previous posts, a high number of Medical Officers in Ontario either work for the University of Toronto, or have gone to school there, or both.

In April 2020, it was announced that Natasha Crowcroft, the former head of CVPD, would join the World Health Organization as their Senior Technical Advisor for measles and rubella control. She still keeps a position at U of T in the meantime.

With the benefit of hindsight, does none of this seem strange? The University of Toronto sets up a group to promote vaccine uptake, and the following year, the same people are running the “pandemic narrative” in Ontario. Many of the Medical Officers also have ties to this institution. Even normies should be asking questions.

(a) https://www.utoronto.ca/news/u-t-opens-groundbreaking-centre-strengthen-vaccine-confidence-through-collaboration
(b) https://www.dlsph.utoronto.ca/institutes/centre-for-vaccine-preventable-diseases/our-people/
(c) https://pubmed.ncbi.nlm.nih.gov/29223487/
(d) https://www.utoronto.ca/news/end-pandemic-near-u-t-expert-urges-patience-following-pfizer-vaccine-update
(e) https://www.theglobeandmail.com/canada/article-university-of-toronto-launches-the-centre-for-vaccine-preventable/
(f) https://www.eventbrite.ca/e/centre-for-vaccine-preventable-diseases-seminar-tickets-79618096871

Also worth a mention, U of T has some interesting donors. True, this is a small amount, but it’s curious to see just who they are accepting money from. Not that it would ever influence how they do business.

A major part of this centre’s mandate will be in finding ways to convince people that vaccines are safe. And what a coincidence, that those services would be needed the following year, on a scale never before seen.

Our Deepest Thanks and Gratitude
.
Since 2011, Boundless: The Campaign for the University of Toronto has engaged thousands of donors to support our highest priorities and aspirations. To date, more than 100,000 alumni, friends and organizations have supported hundreds of vital initiatives that are changing the lives of students and contributing to the health and vibrancy of our society.
.
Campaign Donors
The University wishes to express its thanks to the following benefactors who have made gifts to the Boundless campaign at a level of $25,000 or more. We are grateful to all our donors for helping to establish U of T as a philanthropic priority in Canada, and demonstrating their belief in the University’s pursuit of accessible excellence.

https://boundless.utoronto.ca/our-supporters/donor-listing/

$25,000,000 or more

  • Mastercard Foundation

$10,000,000 to $24,999,999

  • TD Bank Group

$5,000,000 to $9,999,999

  • BMO Financial Group
  • RBC Foundation

$1,000,000 to $4,999,999

  • The Honourable David Peterson
  • AstraZeneca Canada Inc.
  • CIBC
  • Goldcorp Incorporated
  • Google Inc
  • HSBC Bank Canada
  • Loblaw Companies Limited
  • Merck Canada Inc
  • Novartis Pharmaceuticals Canada Inc
  • Pfizer Canada Inc.
  • Scotiabank
  • Sun Life Financial
  • Teva Canada Limited
  • Walmart Canada Corp.

$100,000 to $999,999

  • Amazon Research Awards
  • Aspen Pharmacare Canada Inc.
  • Associated Medical Services
  • Bayer
  • Bayer Inc. Canada
  • BDC Capital
  • Bristol-Myers Squibb Pharmaceutical Group
  • Coca-Cola Company
  • The Dow Chemical Company
  • Eli Lilly Canada Inc.
  • Facebook Canada
  • GlaxoSmithKline
  • Hoffmann-La Roche Ltd.
  • Janssen Inc
  • Johnson & Johnson
  • Johnson & Johnson Medical Companies
  • Mastercard Worldwide
  • Medical Alumni Association, University of Toronto
  • Medical Pharmacies Group Limited
  • Microsoft Canada
  • Microsoft Corporation
  • National Bank of Canada
  • Norton Rose Fulbright Canada LLP
  • Postmedia Network Inc.
  • Power Corporation of Canada
  • Sanofi Canada
  • Sanofi Pasteur Limited
  • TD Waterhouse Canada Inc.
  • Tides Canada Foundation
  • The Tides Foundation

$25,000 to $99,999

  • Aga Khan Trust for Culture
  • Air Canada
  • Alexion Pharma Canada Corp.
  • Alion Pharmaceuticals, Inc
  • ApoPharma Inc.
  • Apotex Foundation / Honey and Barry Sherman
  • Black Creek Investment Management Inc.
  • Blackberry
  • Cargill Incorporated
  • Costco Wholesale Canada Ltd.
  • Deloitte & Touche Foundation Canada
  • Deloitte
  • Gilead Sciences Canada, Inc.
  • McKinsey & Company
  • Microsoft Research Limited
  • Novartis Ophthalmics
  • Pfizer Consumer Healthcare
Posted on

Meet Robert Steiner, (Self-Claimed) Brainchild Behind The Public Health Agency Of Canada

The Ontario Science Table is full of conflicts-of-interest and countless ties to the University of Toronto. However, this piece will mostly focus on one person in the OST: Robert Steiner. From his OST profile, we get this interesting information.

While the Public Health Agency of Canada, or PHAC, had been covered, it seemed that no one person was taking credit for bringing it here. After all, it was a product of the 3rd Edition of the International Health Regulations, imposed by the World Health Organization.

A bit off topic, but another member of OST. Dr. Kwame McKenzie, was the Chair of the Research and Evaluation Advisory Committee of Ontario’s Basic Income Pilot. Yes, he test run what is now coming to Canada. Now, back to Steiner:

Robert Steiner is Assistant Professor and director of journalism and health advocacy programs at the Dalla Lana School of Public Health Sciences, University of Toronto. The Fellowship is the first journalism program designed specifically to teach outstanding specialists with graduate degrees or professional experience in a field how to cover their own disciplines as freelance reporters for media around the world.

Mr. Steiner began his career as a global finance correspondent for The Wall Street Journal with postings in New York, Hong Kong and Tokyo, where he was a finalist for the Pulitzer Prize, won two Overseas Press Club awards and the Inter-American Press Association Award.

After leaving The Wall Street Journal, Mr. Steiner received his MBA from the Wharton School of Business at the University of Pennsylvania. He then worked as a management consultant at The Boston Consulting Group and later led strategic planning for Bell Globemedia, parent of the Globe and Mail and CTV. From 2006 to 2010, Mr. Steiner served as Assistant Vice President of the University of Toronto in charge of Strategic Communications.

Mr. Steiner also served as health and public health policy advisor and principal speechwriter for Paul Martin, during his Liberal Party leadership campaign and transition to being Prime Minister of Canada in 2003. He subsequently advised the Prime Minister’s Office and Cabinet on the creation of the Public Health Agency of Canada in 2004. In 2000, Mr. Steiner had managed the Liberal Party of Canada’s new media campaign in the period leading to and during the federal general election, working for Prime Minister Jean Chretien.

Just in case you missed it, here is the really important part. This is who Steiner claims to be:

Mr. Steiner also served as health and public health policy advisor and principal speechwriter for Paul Martin, during his Liberal Party leadership campaign and transition to being Prime Minister of Canada in 2003. He subsequently advised the Prime Minister’s Office and Cabinet on the creation of the Public Health Agency of Canada in 2004. In 2000, Mr. Steiner had managed the Liberal Party of Canada’s new media campaign in the period leading to and during the federal general election, working for Prime Minister Jean Chretien.

Steiner’s profile with the Ontario Science Table is interesting for a number of reasons. First, he has no medical or science background whatsoever. He is a political science graduate, who later got an MBA. While impressive, it doesn’t explain why the OST would have anything to do with him.

Second, Steiner’s role with the University of Toronto is related to journalism, not science. Again, a strange circumstance.

Third, he acted as a Health Advisor for the Liberal Party of Canada, despite no background in health or science. He claims to be responsible for bringing PHAC here. Strange, since he doesn’t list any affiliation with the United Nations or with WHO. If he was a lawyer, such a move might make sense.

Fourth, he omits his membership with the Trudeau Foundation, both with the OST, and on his LinkedIn page. The association is sketchy enough, but he could at least be transparent about it.

Fifth, he created a company, Whitehall Principal Advisors, which was he supposedly ran while advising Paul Martin on the creation of PHAC. The company has since been shut down, and it’s unclear what, if anything, it ever did.

Now, what is Whitehall Principal Advisors? It used to be a Federally registered corporation. The corporation number was 4251334, and the business number 854746146RC0001. According to Corporations Canada, it was dissolved in 2008, and was delinquent for years in filing annual returns.

Whitehall Principal Advisors Inc 01 Directors
Whitehall Principal Advisors Inc 02 Registered Office
Whitehall Principal Advisors Inc 03 Incorporation
Whitehall Principal Advisors Inc 04 Filing
Whitehall Principal Advisors Inc 05 Dissolution

There isn’t really any information about what this corporation was supposed to be doing, and nothing in the available documents. Steiner was the only Director. Keep in mind, he was supposedly advising Paul Martin on the creation of PHAC during this time.

Whitehall may have been an entirely legitimate operation. And being closed for a decade can explain why there’s no information available. Still, given the timing, it’s worth asking if it was used as a way to pay for services rendered while advising Paul Martin on PHAC.

And here’s another interesting bit of information: Steiner spent years at the University of Toronto, Munk School of Global Affairs & Public Policy. So did Michael Ignatieff, and there is overlap in their tenure. Ignatieff was a Member of Parliament from 2006 until 2011, and even became Liberal Leader, and Leader of the Official Opposition. Ignatieff later went to work for Open Society, George Soros‘ outfit.

Steiner also interviewed Chrystia Freeland when her book “Plutocrats” was released. Interesting topic, since Freeland is now the Finance Minister, hell bent on redistributing everyone’s wealth with the Great Reset.

Robert Steiner is part of the Behavioural Science Working Group with the Ontario Science Table. Their job is come up with psychological and sociological techniques for getting people to comply with the agenda. They even provide scripts for what to say. The obedience training is right out in the open. Check the publication today, as it’s particularly interesting.

What do you think? Is this the man behind PHAC’s creation? Perhaps we should just take him at his word.

Ontario Science Table 01 Behaviour Control Techniques April 22 2021
Ontario Science Table 02 Vaccine Confidence March 5 2021
Ontario Science Table 03 Learning From Israel Feb 1 2021
Ontario Science Table 04 Putting In Harsher Restrictions Oct 15 2021

Posted on

Who’s Behind The Ontario Science Table? A Look At Their Partners And Members

For some background on the University of Toronto, Ontario Science Table, check this earlier article. While it’s true that there the vast majority of these members (and many Medical Health Officers in Ontario) have ties to U of T, there’s more to it than that. Let’s take a look:

It’s important that the Ontario Science Table claims to be independent, yet it’s partners with the Dalla Lana School of Public Health, and the majority of the Table has other ties there. It’s as if OST was simply an extension of U of T. But it gets more interesting from there. There are conflicts of interest everywhere.

  • CADTH, Canadian Agency for Drugs and Technologies in Health
  • Cochrane Canada
  • Dalla Lana School of Public Health, University Of Toronto
  • Public Health Ontario
  • SPOR Evidence Alliance
  • Trillium Health Partners
  • Rob Steiner: PHAC Creator
  • Vinita Dubey: Toronto Associate Medical Officer
  • Other Science Table conflicts of interest

1. CDN Agency Drugs & Technologies in Health

Board of Directors
The 13-member CADTH Board of Directors is composed of an independent chair; a regional distribution of jurisdictional federal, provincial, and territorial representatives; and a number of non-jurisdictional representatives from health systems, academia, and the general public. Directors are elected by the Members of the Corporation, who are the Deputy Ministers of Health for participating federal, provincial, and territorial governments.
.
The Board has overall responsibility for administering the affairs of the Corporation and providing the strategic direction to guide CADTH’s success as the Canadian “go-to” provider of evidence and advice on the use of drugs and other health technologies.

  • David Agnew: held the position of President and CEO of UNICEF Canada, and was the first head of the organization recruited from outside the international development sector. As Principal for the consulting firm Digital 4Sight, he led the firm’s global research initiative on Governance in the Digital Economy. In the co-operative sector, he was the Executive Vice-President and Corporate Secretary for the Credit Union Central of Ontario. Mr. Agnew also held the position of Ombudsman for Banking Services and Investments, the national dispute resolution service for consumers and small businesses. On the boards of directors for Polytechnics Canada, Colleges and Institutes Canada, and the Education Quality and Accountability Office. He is the past Chair of Sunnybrook Health Sciences Centre and of Colleges Ontario. He also serves on numerous other boards and committees, including the Toronto Region Immigrant Employment Council, the Council on Foreign Relations’ Higher Education Working Group on Global Issues, the Sichuan University International Advisory Board, the CivicAction Steering Committee and the Canadian Ditchley Foundation Advisory Board. He is a former member of the federal government’s Science, Technology, and Innovation Council, a former director of ventureLAB and the Empire Club of Canada, and has served on the campaign cabinets of the United Way in Toronto and Peel.
  • Marcel Saulnier, Associate Assistant Deputy Minister, Strategic Policy Branch, Health Canada
  • Western Provinces, Mitch Moneo, Assistant Deputy Minister, Pharmaceutical Services Division, Ministry of Health, British Columbia
  • Mark WyattMark Wyatt, Assistant Deputy Minister, Saskatchewan Ministry of Health
  • Territories, Stephen Samis, Deputy Minister, Health and Social Services, Government of Yukon
  • Ontario, Patrick Dicerni, Assistant Deputy Minister, Drugs and Devices Division and Executive Officer, Ontario Public Drug Programs
  • Atlantic Provinces, Jeannine Lagassé, Associate Deputy Minister of Health and Wellness, Province of Nova Scotia.
  • Karen Stone, Deputy Minister of Health and Community Services (NL)
  • Health Systems, Dr. Brendan Carr, President and CEO of the Nova Scotia Health Authority
  • Dr. Charmaine RoyeDr. Charmaine Roye, Physician, Ottawa
  • Public, Cathy McIntyre, Principal of Strategic Initiatives
  • Ellen Pekilis, Legal, Risk and Governance Advisor
  • Academic, Dr. Stuart Peacock, Leslie Diamond Chair in Cancer Survivorship and Professor, Faculty of Health Sciences, Simon Fraser University; Co-Director, the Canadian Centre for Applied Research in Cancer Control (ARCC); and Distinguished Scientist in Cancer Control Research, British Columbia Cancer Agency
  • Observer (Quebec), Dr. Luc Boileau, President and CEO, Institut national d’excellence en santé et en services sociaux (INESSS)

Actual high ranking bureaucrauts are Directors of this organization. Forget independence from Government, this is the Government being represented here.

CADTH calls itself and independent and non-partisan group that provides information and recommendations for decision makers in health care.

2. Cochrane Canada

Cochrane Canada is affiliated with 26 partner organizations, each with a designated representative who liaises with our Knowledge Broker. Collaboration with other health organizations is an essential part of our mission to bring the use of evidence into healthcare decision-making. We collaborate with our partners to promote awareness, understanding and use of Cochrane Reviews to their members through activities such as workshops, webinars and online promotion.
.
The guidelines for becoming a partner organization can be reviewed here. If you are interested in partnering with Cochrane Canada, please contact us. The partner terms of reference set out the eligibility and responsibility of the partner relationship.

One of the Ontario Science Table’s partners is Cochrane Canada. While claiming to be an “independent global network” of healthcare practitioners and researchers, it’s partnered with the World Health Organization.

3. Dalla Lana School of Public Health, U Of T

  • Barbara Yaffe – Ontario Deputy Medical Officer
  • Eileen De Villa – Toronto Chief Medical Officer
  • Vinita Dubey – Toronto Associate Medical Officer of Health
  • Lisa Berger – Toronto Associate Medical Officer of Health
  • Christine Navarro – Toronto Associate Medical Officer of Health
  • Avis Lynn Noseworthy – Medical Officer of Health for the Haliburton, Kawartha, Pine Ridge
  • Vera Etches – Ottawa Deputy Medical Officer of Health
  • Brent Moloughney – Ottawa Associate Medical Officer
  • Lawrence C. Loh – Peel Medical Officer of Health
  • Hamidah Meghani – Halton Region Medical Health Officer
  • Nicola Mercer – Wellington-Dufferin-Guelph Medical Officer (UofT Medical School)
  • Mustafa Hirji – Niagara Acting Medical Officer of Health (U of T graduate)
  • Elizabeth Richardson – Hamilton Medical Officer of Health (U of T graduate)

The Dalla Lana School of Public Health is part of the University of Toronto. DLSPH is also partnered with the Ontario Science Table. Seems pretty strange that so many “Medical Officers” in Ontario either have attended U of T, and/or are Professors there.

4. Public Health Ontario

The Ontario COVID-19 Science Advisory Table is a group of scientific experts and health system leaders who evaluate and report on emerging evidence relevant to the COVID-19 pandemic, to inform Ontario’s response.
.
The Science Table’s mandate is to provide weekly summaries of relevant scientific evidence for the COVID-19 Health Coordination Table of the Province of Ontario, integrating information from existing scientific tables, Ontario’s universities and agencies, and the best global evidence. The Science Table summarizes its findings for the Health Coordination Table and for the public in Science Briefs.
.
The Science Table is an independent group, hosted by the Dalla Lana School of Public Health. There is no compensation for serving on the Science Table. However, the Scientific Director and the Secretariat are funded by the Dalla Lana School of Public Health and Public Health Ontario.

The Ontario Science Table claims to be an independent group, get admits it gets funding from PLSPH, and Public Health Ontario. Consider just how many people (and Medical Officers of Health) have ties to the University of Toronto. Also consider, that PHO’s agenda is in keeping this “pandemic” alive. It’s difficult to see the OST as anything other than the propaganda arm of those groups.

5. SPOR Evidence Alliance

The SPOR Evidence Alliance is made possible by a five-year grant from the Canadian Institutes of Health Research (CIHR) under Canada’s Strategy for Patient-Oriented Research (SPOR) Initiative, and the generosity of sponsors from 41 public agencies and organizations across Canada who have made cash or in-kind contributions.

SPOR Evidence Alliance also claims to be independent, but is partnered with the World Health Organization. This seems to be a pattern. Several universities are also listed as partners.

6. Trillium Health Partners

  • Michelle E. DiEmanuele is President and CEO of Trillium Health Partners. She has spent her career in the public and private sectors leading large-scale change and cultural transformation. Previously, Michelle was Associate Secretary of Cabinet and Deputy Minister in the Ontario Government. During this time, she led the renewal of public services through “Service Ontario” including the introduction of the first ever “Money Back Guarantee” for government services in North America. She reformed human resources, information technology and business services for the Ontario Government. She has also served as Interim CEO at the Ontario Lottery and Gaming Corporation, Assistant Deputy Minister of Health, Vice President (Branch and Small Business Banking, Retail Markets/Human Resources), CIBC and Vice President (Human Resources and Organizational Development), Brookfield Properties Ltd.
  • Karli Farrow is a leader who has been a part of transformation designed to improve public services in Ontario for over fifteen years. She is the Senior Vice-President, Strategy, People and Corporate Affairs and is accountable for leading critical enabling functions including strategy and project management, human resources, organizational development, public affairs and corporate governance. Karli joined the previous Credit Valley Hospital and Trillium Health Centre in 2009 and in 2011 provided project leadership to support the merger of the two organizations. Prior to joining Trillium Health Partners, Karli worked for a health care consulting company where she led critical projects focused on reducing wait times and improving chronic disease management. She has also served in senior advisory roles for the government of Ontario, including Director of Policy for the Premier of Ontario and Chief of Staff to the Minister of Health and Long-Term Care. In these roles she worked to develop and implement strategies to improve access to care and the long-term sustainability of the health care system in Ontario.

In addition to many of the leadership and Board attending the University of Toronto, a few have also been high ranking officials in the Provincial Government. Could be why there is nothing to objectionable about what Ford is doing. Interestingly, several of them have ties to major banks.

7. Honourable Mention: Rob Steiner

Mr. Steiner also served as health and public health policy advisor and principal speechwriter for Paul Martin, during his Liberal Party leadership campaign and transition to being Prime Minister of Canada in 2003. He subsequently advised the Prime Minister’s Office and Cabinet on the creation of the Public Health Agency of Canada in 2004. In 2000, Mr. Steiner had managed the Liberal Party of Canada’s new media campaign in the period leading to and during the federal general election, working for Prime Minister Jean Chretien.

Steiner helped create the Public Health Agency of Canada, as per the new International Health Regulations, and was there when the Quarantine Act was passed. He’s also a longtime Liberal Party operative. Steiner is also a member of the Trudeau Foundation, but why should that matter?

8. Honourable Mention: Vinita Dubey

Dubey is a special circumstance. She is an Associate Medical Officer of Health for Toronto, working under Eileen De Villa. Both Dubey and De Villa are Professors at the University of Toronto. However, Dubey is also part of the ironically named Ontario Science Table, providing cover for her boss to impose the measures that she does.

9. Other Serious Conflicts Of Interest

  • Trevor Arnason: has an MD from the University of Toronto, and did a combined residency in Public Health and Preventive Medicine and Family Medicine at the University of Ottawa. In 2016, he moved to the east coast to be the Regional Medical Officer of Health for Halifax where he worked on several health promotion initiatives and co-led responses to multiple vaccine preventable disease outbreaks including one of the largest measles outbreaks in Canada in recent years. In January 2019, he returned to his hometown to work as an Associate Medical Officer of Health with Ottawa Public Health where is consultant to the vaccination and sexually transmitted and bloodborne infections portfolio. He also works part-time as a family doctor in an urgent care clinic.
  • Adalsteinn Brown: Prior to becoming Dean, he was the Director of the Institute of Health Policy, Management and Evaluation and the Dalla Lana Chair of Public Health Policy also at the University. Other past roles include head of strategy for the Ontario Ministry of Health and Long-term Care and the head of policy and science for the Ontario Ministry of Research and Innovation.
  • Anne Hayes: Director, Research, Analysis and Evaluation Branch, Strategic Policy, Planning and French Language Services Division, Ministries of Health and Long-Term Care
  • Melanie Kohn: worked in the Ontario public healthcare sector for almost 20 years. In July 2020, she was appointed Assistant Deputy Minister, Mental Health and Addictions, overseeing the funding and operations of the sector, the realization of the Roadmap to Wellness, and to support standing up the Mental Health and Addictions Centre of Excellence at Ontario Health. In 2016, Melanie joined the Ministry of Health as the inaugural Director of the Hospitals Branch. She was responsible for overseeing the operations, finances, and administration of the Public and Private Hospital Acts providing legislative and regulatory oversight for the province’s 145 hospitals.
  • Dr. Kwame McKenzie: previously a Human Rights Commissioner for Ontario and Chair of the Research and Evaluation Advisory Committee of Ontario’s Basic Income Pilot. In addition to his academic, policy and clinical work, Kwame has been a columnist for the Guardian, Times-online and Toronto Star and a past BBC Radio presenter.
  • David McKeown: the Associate Chief Medical Officer of Health for the province of Ontario, with responsibility for supporting the provincial covid-19 response. He is a physician specialist who has worked in the public health field for over 30 years. From 2004-2016 he led Toronto Public Health, Canada’s largest local public health agency, serving a diverse population of 2.7 million people. He has also served as the Medical Officer of Health for East York, the Region of Peel, and the former City of Toronto prior to municipal amalgamation. Dr. McKeown led the local public health response to the H1N1 pandemic, a major outbreak of Legionnaire’s Disease, and the first outbreak of West Nile Virus in Canada.
  • Rhiannon Mosher: Senior Policy Advisor for the Ontario government’s Behavioural Insights Unit (BIU). In this role, she works with partners in ministries across Ontario and other public sector organizations to help improve program and service delivery through evidence-based, human-centred solutions. Rhiannon has helped design and test solutions to improve programs and service in health, labour, and transportation. Most recently, she has been supporting work to inform the province’s response to COVID-19.
  • Sumit Raybardhan: Board Certified Infectious Diseases Pharmacist that practices at North York General Hospital, where he also co-leads the Antimicrobial Stewardship Program. His post-graduate work included a Masters in Public Health specializing in Epidemiology and International Health from Boston University. He has had experiences in the institutional hospital setting as a clinical pharmacist and at regional and international organizations such as Public Health Ontario, UNICEF, and Medicines for Malaria Venture. He currently focuses on pragmatic practice-based research on optimizing antimicrobial use.
  • Brian Schwartz: provides executive leadership for PHO’s public health science and population health programs including environmental and occupational health, health promotion, chronic disease and injury prevention, and research and ethics services. Previous portfolios include health protection, emergency preparedness, communicable diseases and infection prevention and control. Dr. Schwartz served as Scientific Advisor to the Emergency Management Branch of the Ministry of Heath and Long Term Care from 2004 to 2011, and was Public Health Ontario’s inaugural Chief of Emergency Management Support. He acted as Vice-chair of the Ontario SARS Scientific Advisory Committee in 2003 and was Chair of the Scientific Response Team for the 2009 H1N1 pandemic.
  • Premy Selvakumar: currently works at Public Health Ontario as an Administrative Assistant in the Health Promotion, Chronic Disease, Injury Prevention Department. She has over 10 years of administrative experience and has supported a variety high level of executives. She holds a Bachelor of commerce degree with a major in Human Resources and a minor in Marketing.

10. Does Anything Seem Wrong With This?

The Ontario Science Table presents itself as a neutral group of “experts”, offering insight into what is actually going on. Now, this doesn’t sound bad in principle.

The problem is that people on this panel are former (and current) Government officials. Groups that OST partners with also have former (and current) Government officials working for them. A few groups even partner with the World Health Organization. There are also Medical Officers of Health working for the OST, and serving as Faculty members for the University of Toronto — a partner organization.

How can it be taken seriously as anything other than an extension of the Government? The ties just run way too deep.

Posted on

CV# 66(6): WHO Policy Paper On MANDATORY “Vaccines”, Admitting They’re Experimental

Less than a year ago, this was decried as a conspiracy theory cooked up by paranoid tinfoil hatters. Now, the World Health Organization is openly discussing policies of MANDATORY injections. And to clarify, all of these gene-replacement “vaccines” are still considered experimental. They are authorized for emergency measures, but are not actually approved.

WHO Paper On MANDATORY Vaccination April 13, 2021 (Original)
WHO Paper On MANDATORY Vaccination April 13, 2021 (Copy)
Section 30.1 Canada Food & Drug Act
September 2020 Interim Order From Patty Hajdu
https://covid-vaccine.canada.ca/info/pdf/astrazeneca-covid-19-vaccine-pm-en.pdf
https://covid-vaccine.canada.ca/info/pdf/janssen-covid-19-vaccine-pm-en.pdf
https://covid-vaccine.canada.ca/info/pdf/covid-19-vaccine-moderna-pm-en.pdf
https://covid-vaccine.canada.ca/info/pdf/pfizer-biontech-covid-19-vaccine-pm1-en.pdf

Testing Product Insert AstraZeneca Interim Authorization
Testing Product Insert Janssen Interim Authorization
Testing Product Insert Moderna Interim Authorization
Testing Product Insert Pfizer Interim Authorization

Before going any further, it is time to distinguish between 2 completely different ways medical devices and substances can be advanced.

(a) Approved: Health Canada has fully reviewed all the testing, and steps have been done, with the final determination that it can be used for the general population
(b) Interim Authorization: deemed to be “worth the risk” under the circumstances, doesn’t have to be fully tested. Allowed under Section 30.1 of the Canada Food & Drug Act. Commonly referred to as an emergency use authorization.

To be approved means that this thing has been rigorously tested, and has passed all safety measures, and that it has rigorously been examined. This is not what happened here. Instead, these “vaccines” were given interim authorization, because the Government has decided that it’s worth releasing it to the general public, and finishing the testing later. This is allowed under Section 30.1 of the Canada Food & Drug Act, and an Interim Order was signed by Patty Hajdu.

Think this is an exaggeration? Take a look at the paperwork available from Health Canada. Not once do they refer to them as approved. Instead, they are “authorized under an Interim Order”. These are not the same thing, and cannot be used interchangeably. Now, let’s get to the WHO paper.

Vaccines are one of the most effective tools for protecting people against COVID-19. Consequently, with COVID-19 vaccination under way or on the horizon in many countries, some may be considering whether to make COVID-19 vaccination mandatory in order to increase vaccination rates and achieve public health goals and, if so, under what conditions, for whom and in what contexts

Right off the bat, there is no semblance of neutrality. The World Health Organization starts off with the assumption that these are safe and effective. So legitimate concerns about testing, long term side effects, and the necessity of these “vaccines” is minimized.

It is not uncommon for governments and institutions to mandate certain actions or types of behaviour in order to protect the well-being of individuals or communities. Such policies can be ethically justified, as they may be crucial to protect the health and well-being of the public. Nevertheless, because policies that mandate an action or behaviour interfere with individual liberty and autonomy, they should seek to balance communal well-being with individual liberties. While interfering with individual liberty does not in itself make a policy intervention unjustified, such policies raise a number of ethical considerations and concerns and should be justified by advancing another valuable social goal, like protecting public health.
.
This document does not provide a position that endorses or opposes mandatory COVID-19 vaccination. Rather, it identifies important ethical considerations and caveats that should be explicitly evaluated and discussed through ethical analysis by governments and/or institutional policy-makers who may be considering mandates for COVID-19 vaccination.

Interesting. This paper attempts to take a neutral and academic approach towards the idea of forced vaccinations (or gene replacement therapy). How exactly does someone take a neutral stance on forcing millions, or billions, or people to take experimental drugs? Is this really necessary for safety?

How do you balance: (a) your right to self autonomy and control over your own body, and (b) the doomsday predictions of sociopathic politicians, and corrupt scientists?

1. Necessity and proportionality
Mandatory vaccination should be considered only if it is necessary for, and proportionate to, the achievement of an important public health goal (including socioeconomic goals) identified by a legitimate public health authority. If such a public health goal (e.g., herd immunity, protecting the most vulnerable, protecting the capacity of the acute health care system) can be achieved with less coercive or intrusive policy interventions (e.g., public education), a mandate would not be ethically justified, as achieving public health goals with less restriction of individual liberty and autonomy yields a more favourable risk-benefit ratio.
.
As mandates represent a policy option that interferes with individual liberty and autonomy, they should be considered only if they would increase the prevention of significant risks of morbidity and mortality and/or promote significant and unequivocal public health benefits. If important public health objectives cannot be achieved without a mandate – for instance, if a substantial portion of individuals are able but unwilling to be vaccinated and this is likely to result in significant risks of harm – their concerns should be addressed, proactively if possible. If addressing such concerns is ineffective and those concerns remain a barrier to achievement of public health objectives and/or if low vaccination rates in the absence of a mandate put others at significant risk of serious harm, a mandate may be considered “necessary” to achieve public health objectives. In this case, those proposing the mandate should communicate the reasons for the mandate to the affected communities through effective channels and find ways to implement the mandate such that it accommodates the reasonable concerns of communities. Individual liberties should not be challenged for longer than necessary. Policy-makers should therefore frequently re-evaluate the mandate to ensure it remains necessary and proportionate to achieve public health goals. In addition, the necessity of a mandate to achieve public health goals should be evaluated in the context of the possibility that repeated vaccinations may be required as the virus evolves, as this may challenge the possibility of a mandate to realistically achieve intended public health objectives.

Our “leaders” rely on computer modelling and data manipulation in order to drive these predictions. Therefore, the case of necessity can always be skewed. Liberties should not be challenged longer than necessary, yet the only way to achieve it — at some point — is to take experimental drugs.

Not only should we consider mandating these “vaccines”, we should also consider if more and more will be needed to deal with mutations of it.

There’s little to no concern about the long term effects of these “vaccines”. In fact, the authors parrot the talking points that they are safe and effective. The only issue seems to be about making it required if they cannot “educate” the public in sufficient numbers.

2. Sufficient evidence of vaccine safety
.
Data should be available that demonstrate the vaccine being mandated has been found to be safe in the populations for whom the vaccine is to be made mandatory. When safety data are lacking or when they suggest the risks associated with vaccination outweigh the risks of harm without the vaccine, the mandate would not be ethically justified, particularly without allowing for reasonable exceptions (e.g., medical contraindications). Policy-makers should consider specifically whether vaccines authorized for emergency or conditional use meet an evidentiary threshold for safety sufficient for a mandate. In the absence of sufficient evidence of safety, there would be no guarantee that mandating vaccination would achieve the goal of protecting public health. Furthermore, coercive exposure of populations to a potentially harmful product would violate the ethical obligation to protect the public from unnecessary harm when the harm the product might cause outweighs the degree of harm that might exist without the product. Even when the vaccine is considered sufficiently safe, mandatory vaccination should be implemented with no-fault compensation schemes to address any vaccine-related harm that might occur. This is important, as it would be unfair to require people who experience vaccine-related harm to seek legal remedy from harm resulting from a mandatory intervention. Such compensation would depend on countries’ health systems, including the extent of universal health coverage and how they address harm from vaccines that are not fully licensed (e.g., vaccines authorized for emergency or conditional use).
.
3. Sufficient evidence of vaccine efficacy and effectiveness
.
Data on efficacy and effectiveness should be available that show the vaccine is efficacious in the population for whom vaccination is to be mandated and that the vaccine is an effective means of achieving an important public health goal. For instance, if mandatory vaccination is considered necessary to interrupt transmission chains and prevent harm to others, there should be sufficient evidence that the vaccine is efficacious in preventing serious infection and/or transmission. Alternatively, if a mandate is considered necessary to prevent hospitalization and protect the capacity of the acute health care system, there should be sufficient evidence that the vaccine is efficacious in reducing hospitalization. Policy-makers should carefully consider whether vaccines authorized for emergency or conditional use meet evidentiary thresholds for efficacy and effectiveness sufficient for a mandate.

Here we get to the heart of it. The World Health Organization mentions that policy makers might consider a mandate, even if these gene replacement “vaccines” have only emergency or conditional authorization. As mentioned earlier, that is what status the chemicals in Canada have.

Vaccine compensation programs should be established, but that leaves out a key detail. It’s not the drug manufacturers who would be paying for such injuries. It would be funded by the public. Privatized profits, socialized losses.

There’s also the interesting question: if an experimental or emergency use “vaccine” is taken, who actually is responsible for it?

Mandatory COVID-19 vaccination in context
.
Authorized COVID-19 vaccines have been shown to be safe and efficacious in preventing severe disease and death, and it is clear that vaccine supply will continue to increase globally, albeit inequitably. That being said, the nature of the COVID-19 pandemic and evidence on vaccine safety, efficacy, and effectiveness continue to evolve (including with respect to variants of concern). Consequently, the six considerations identified above are described generally so that they can be applied at any point in time and in any context. For illustrative purposes, we now turn our attention to the application of these ethical considerations in three settings for which mandatory vaccination is commonly discussed: for the general public, in schools, and for health workers.

Within this paragraph, it’s stated that authorized vaccines (again, not approved), are safe and efficacious. Then, it immediately claims this will continue to evolve. In other words, these “safety” guarantees are worth nothing.

Conclusions
Vaccines are effective for protecting people from COVID-19. Governments and/or institutional policy-makers should use arguments to encourage voluntary vaccination against COVID-19 before contemplating mandatory vaccination. Efforts should be made to demonstrate the benefit and safety of vaccines for the greatest possible acceptance of vaccination. Stricter regulatory measures should be considered only if these means are not successful. A number of ethical considerations and caveats should be explicitly discussed and addressed through ethical analysis when considering whether mandatory COVID-19 vaccination is an ethically justifiable policy option. Similar to other public health policies, decisions about mandatory vaccination should be supported by the best available evidence and should be made by legitimate public health authorities in a manner that is transparent, fair, non-discriminatory, and involves the input of affected parties.

WHO Paper On MANDATORY Vaccination April 13, 2021 (Original)
WHO Paper On MANDATORY Vaccination April 13, 2021 (Copy)

Use arguments first. Mandate only if that doesn’t work. In other words, if we can’t persuade people to take it willingly, then consider forcing them. Funny how “involves the input of affected parties” gets in there. If these are mandated, then of course input is removed.

Don’t you love it when academic debate what our human rights should be, and what bodily autonomy we should have?

References
1. Nuffield Council on Bioethics. Public health: Ethical issues. London: Nuffield Council on Bioethics; 2007
(https://www.nuffieldbioethics.org/assets/pdfs/Public-health-ethical-issues.pdf).
2. Gravagna K, Becker A, Valeris-Chacin R, Mohammed I, Tambe S, Awan FA et al. Global assessment of national
mandatory vaccination policies and consequences of non-compliance. Vaccine. 2020;38:7865–73.
3. Colgrove J, Bayer R. Manifold restraints: Liberty, public health, and the legacy of Jacobson v Massachusetts. Am J Public
Health. 2005;95:571–6.
4. World Health Organization. COVID-19 virtual press conference 7 December 2020
(https://www.who.int/publications/m/item/covid-19-virtual-press-conference-transcript—7-december-2020).
5. World Health Organization. Interim position paper: Considerations regarding proof of COVID-19 vaccination for
international travellers. Geneva: World Health Organization; 2021 (https://www.who.int/news-room/articles-detail/interim-position-paper-considerations-regarding-proof-of-covid-19-vaccination-for-international-travellers).
6. Walkinshaw E. Mandatory vaccinations: The international landscape. Can Med Assoc J. 2011;183:e1167–8.
7. Gostin LO, Salmon DA, Larson HJ. Mandating COVID-19 vaccines. JAMA. 2020;325:532–3.
8. Halabi S, Heinrich A, Omer S. No-fault compensation for vaccine injury – The other side of equitable access to Covid-19
vaccines. N Engl J Med. 2020;383:e125.
9. Schwartz JL. Evaluating and deploying Covid-19 vaccines – The importance of transparency, scientific integrity, and
public trust. N Engl J Med. 2020;383:1703–5.
10. Shetty P. Experts concerned about vaccination backlash. Lancet. 2020;375:970–1.
11. Giubilini A. Chapter 3, Vaccination policies and the principle of least restrictive alternative: An intervention ladder. In
Giubilini A, The ethics of vaccination. Cham (CH): Palgrave Pivot; 2019.
12. Goldenberg M. Vaccine hesitancy: Public trust, expertise, and the war on science. Pittsburgh, PA: University of Pittsburgh
Press. 2021.
13. Opel DJ, Lo B, Peek ME. Addressing mistrust about COVID-19 vaccines among patients of color. Ann Intern Med.
2021;M21-0055. doi: 10.7326/M21-0055.
14. Colgrove J. Immunization and ethics: Beneficence, coercion, public health, and the state. In: Mastroianni AC, Kahn JP,
Kass NE, editors. The Oxford handbook of public health ethics, New York City (NY): Oxford University Press; 2020:435–
44.
15. Sutton EJ, Upshur REG. Are there different spheres of conscience? J Eval Clin Pract. 2010;16:338–43.
16. Harris J, Holm S. Is there a moral obligation not to infect others? BMJ. 1995;311:1215–7.
17. Gruben V, Siemieniuk RA, McGeer A. Health care workers, mandatory influenza vaccination policies and the law. Can
Med Assoc J. 2014;186:1076–80.
18. Krystal JH. Responding to the hidden pandemic for healthcare workers: Stress. Nat Med. 2020;26:639.
19. Van Buynder PG, Konrad S, Kersteins F, Preston E, Brown PD, Keen D, et al. Healthcare worker influenza immunization
vaccinate or mask policy: Strategies for cost effective implementation and subsequent reductions in staff absenteeism due
to illness. Vaccine. 2015;33:625–8.
20. Caplan A, Shah NR. Managing the human toll caused by seasonal influenza: New York State’s mandate to vaccinate or
mask. JAMA. 2013;310:1797–8.
21. World Health Organization. Mask use in the context of COVID-19 – Interim guidance. Geneva: World Health
Organization; 2020. (https://www.who.int/publications/i/item/advice-on-the-use-of-masks-in-the-community-duringhome-care-and-in-healthcare-settings-in-the-context-of-the-novel-coronavirus-(2019-ncov)-outbreak)

Posted on

Getting Government Certified In Contact Tracing: No Skill Or Patience Required

Do you have an hour to kill? Want to become a government certified contact tracer? Now it’s even easier than ever. No real skill, talent, or hard work required.
https://training-formation.phac-aspc.gc.ca/?lang=en
https://training-formation.phac-aspc.gc.ca/course/
https://training-formation.phac-aspc.gc.ca/course/view.php?id=296

Side note: I notice that several of the questions imply that you may have multiple sexual partners. Almost as if there was some agenda going on.

CONTACT TRACING INTERVIEWING

It turns out that turning in someone who’s here illegally is actually the wrong answer. One would think that border enforcement is a serious topic, but the Public Health Agency of Canada doesn’t see it that way.

SUPPLEMENTAL TRAINING

The supplemental sections did cram a lot of social justice nonsense into it, such as privilege and oppression. However, we have to power through it (or just keep hitting skip), in order to get move on.

The public health section has a lot of history lessons, but very little useful information. Yes, this entire article has basically just been trolling, but it wasn’t that painful.

Posted on

Who Is Ontario Deputy Medical Officer Barbara Yaffe?

The now infamous clip of Barbara Yaffe telling Ontario that these testing methods can result in 50% false positives. Amazingly, she has never faced real scrutiny from this.

It’s interesting how little information is available on Yaffe, considering she has been in a position of power for years. In some ways, this looks like another Theresa Tam.

https://www.linkedin.com/in/barbara-yaffe-b5395111/
https://archive.is/eaKt7
https://doctors.cpso.on.ca/DoctorDetails/Barbara-Ann-Yaffe/0026394-31217
https://opengovca.com/ontario-employee/Yaffe,_Barbara
https://mds.servicerating.ca/office/p-a-rostas-medicine-professional-corporation
https://academic.oup.com/pch/article/5/6/319/2655770?login=true
Canadian Journal Of Public Health
https://www.nejm.org/doi/full/10.1056/NEJMoa032111
https://academic.oup.com/cid/article/62/2/139/2462731?login=true
https://www.dlsph.utoronto.ca/faculty-profile/yaffe-barbara/
https://www.dlsph.utoronto.ca/faculty-profile/de-villa-eileen/
https://www.dlsph.utoronto.ca/faculty-profile/moloughney-brent/
CIHR Grants To Conduct Modelling, Other Research (2020)
Ottawa Announcing Grants For CV-19 Research
UofT “Modellers” Getting More Taxpayer Money (2021)
April 17, 2020 Memo To Ontario Doctors
National Collaborating Centre For Infectious Diseases
U of Toronto, McMaster Claim To Have Isolated Covid-19
Fluoride Free Peel On UofT Virus Isolation

Barbara Yaffe is more than just on the “Sunshine List” for Ontario. She’s taking in over $250,000 per year, plus a generous benefits program, courtesy of taxpayers. That’s in addition to the money she gets moonlighting as a Professor for the University of Toronto. For that kind of money, one would hope that the Province is getting a skilled professional. However, her work history isn’t all that impressive.

Yaffe is also part of the NCCID, which aims on implementing aspects of public health into all areas of life. She is a Member, and on the Advisory Board. However, it’s unclear what, if anything, she actually does.

Yaffe is still 1 of 2 registered shareholders of P.A. Rostas Medicine Professional Corporation, which “appears” to be a medical practice set up in 2008, but no information is available about it.

Not only is Yaffe paid quite well, it appears that the entire upper echelon of Ontario Health is making great salaries. Seems none of them have lost jobs, or been forced onto EI or CERB.

Keep in mind, Yaffe blurted out last December that she “only says what they write down for [her]”. This suggests she is little more than a puppet for the political masters. As for her education, she’s a lifer at U of T.

1974 – University of Toronto, General Science
1978 – University of Toronto, Medical Degree
1981 – University of Toronto, Masters of Public Health
1983 – University of Minnesota, Epidemiology (online?)
1984 – University of Toronto, Fellowship in Public Health and Preventative Medicine

That’s from the LinkedIn page. The CPSO profile simply lists medical school in 1978, and a specialty in “Community Medicine” in 1984. Is the LinkedIn page fake? Or is the professional CPSO profile missing information? Anyhow, the “ABOUT” section on LinkedIn states:

I am a public health physician with over 30 years of experience working in local public health in Toronto, Ontario, both as a Medical Officer of Health and as an Associate MOH. My current position is Director of Communicable Disease Control and Associate MOH with Toronto Public Health. My areas of interest include the prevention and control of infectious diseases and emergency preparedness and response, but also much broader areas of public health. My work has increasingly focused on identifying and helping to address the unique needs of our diverse populations and communities – new immigrants/refugees, the homeless, drug users etc. My work involves collaboration with multiple stakeholders (local, provincial and national), advocacy, policy development and program implementation. I am interested in contributing to public health at a national and international level as possible.

If this is to be taken at face value, Yaffe has been a political operative in Ontario for over 30 years. This means she hasn’t actually practiced medicine much, if at all. Yaffe’s talent seems to be in helping write papers on the topic of population control measures. More can be found on Google Scholar. Here are a few of them.

In September 2000, Yaffe co-authored a paper for Oxford Academic that outlined measures should a terrorist attack happen in Canada. If it wasn’t predictive programming, it’s quite the coincidence.

In 2004, Sheela V. Basrur, Barbara Yaffe and Bonnie Henry wrote for the Canadian Journal of Public Health outlining the quarantine, contact tracing and restrictions of movement around SARS.

In 2004, Yaffe co-authored (along with Bonnie Henry) a piece in the New England Journal of Medicine called: Public Health Measures to Control the Spread of the Severe Acute Respiratory Syndrome during the Outbreak in Toronto.

From the last 2004 SARS paper:

METHODS
We analyzed SARS case, quarantine, and hotline records in relation to control measures. The two phases of the outbreak were compared.
.
CONCLUSIONS
The transmission of SARS in Toronto was limited primarily to hospitals and to households that had had contact with patients. For every case of SARS, health authorities should expect to quarantine up to 100 contacts of the patients and to investigate 8 possible cases. During an outbreak, active in-hospital surveillance for SARS-like illnesses and heightened infection-control measures are essential.
.
QUARANTINE AND CALLS TO THE HOTLINE
During the outbreak, 23,103 contacts were identified as requiring quarantine (Figure 2). Of those in quarantine, 27 (0.1 percent) were issued a legally enforceable quarantine order owing to initial noncompliance. A breakdown of 316,615 calls to the Toronto Public Health SARS hotline is given in Table 1. The most common reason for calling was to discuss potential exposures.

Even back in 2003/2004, these public health officials were discussing and research details and methods related to quarantine and contact tracing. Not that it will ever be abused some day.

Yaffe is also an Associate Professor at the Dalla Lana School of Public Health at the University of Toronto. So is Eileen De Villa, Toronto Medical Health Officer. De Villa has her own backstory, as explained by Stormhaven and Diverge Media. Brent Moloughney is the Associate Medical Officer for Ottawa, and also a Dalla Lana Professor. Notice a trend?

In 2020, at least 9 people at the University of Toronto got grants from the CIHR, Canadian Institutes for Health Research, for Covid-19, some of it to conduct modelling.

  • Roy Gillis of the department of applied psychology and human development at the Ontario Institute for Studies in Education: Responding to the stigma, fear, discrimination and misinformation related to the COVID-19 disease outbreak – a novel analyses and intervention for a novel coronavirus
  • Shaf Keshavjee of the department of surgery in the Faculty of Medicine and the University Health Network: Reducing the health-care resource burden from COVID-19 (SARS-CoV-2) –Rapid diagnostics to risk-stratify for severity of illness
  • Robert Maunder of the department of psychiatry in the Faculty of Medicine and Sinai Health System: Peer champion support for hospital health-care workers during and after a novel coronavirus outbreak: It’s a marathon, not a sprint
  • Vijaya Kumar Murty of the department of mathematics in the Faculty of Arts & Science and the Fields Institute for Research in Mathematical Sciences: Agent-based and multi-scale mathematical modelling of COVID-19 for assessments of sustained transmission risk and effectiveness of countermeasures
  • James Rini of the departments of biochemistry and molecular genetics in the Faculty of Medicine: Neutralizing antibodies as SARS-CoV-2 therapeutics
  • Simron Singh of the Dalla Lana School of Public Health and the department of medicine in the Faculty of Medicine and Sunnybrook Health Sciences Centre: Assessment of cancer patient and caregiver perspective on the novel coronavirus (COVID-19) and the impact on delivery of cancer care at an institution with a confirmed case of COVID-19
  • Darrell Tan of the Institute of Health Policy, Management and Evaluation at the Dalla Lana School of Public Health and department of medicine in the Faculty of Medicine and St. Michael’s Hospital: COVID-19 ring-based prevention trial for undermining spread (CORPUS)
  • Xiaolin Wei of the Institute of Health Policy, Management and Evaluation at the Dalla Lana School of Public Health: Developing integrated guidelines for health-care workers in hospital and primary health-care facilities in response to Covid-19 pandemic in low- and mddle-Income countries (LMICs)
  • Xiao-Yan Wen of the department of physiology in the Faculty of Medicine and St. Michael’s Hospital: Therapeutic development for COVID-19 coronavirus-induced sepsis and ARDS targeting vascular leakage

Even going back to March 2020, Ottawa was handing out money everywhere to conducting research on Covid-19. Overnight, it became a growth industry for researchers looking for work. The grants have continued into 2021.

This is nowhere near exhaustive, and a deeper dive will surely uncover far more grants being doled out.

Even as groups like the CIHR are shelling out money to conduct modelling and “response plans”, they are also funding efforts to convince people that vaccines are safe. A significant conflict of interest.

With lives at stake, and large amounts of taxpayer money, one would think that oversight and review mechanisms would be tighter.

Some of the research went to (at least allegedly) for isolating and purifying Covid-19. In fact, the University of Toronto proudly broadcast that achievement as a marvel of modern science. On March 13, 2020, a prominent article was posted on the University website.

While that sounds great, it doesn’t seem to withstand scrutiny. An organization called Fluoride Free Peel has been looking for proof isolation from all over the world. When presented with a freedom of information request, there were “no records available”. What happened? Was this contracted out to some 3rd party, or was there never any isolation to begin with?

The University of Toronto is receiving large amounts of money in the name of pandemic research. Barbara Yaffe (and Eileen De Villa), are both Faculty Members at U of T. At the same time, both are Medical Officers, with De Villa in Toronto, and Yaffe Provincially. They are able (at least in theory) to use their positions of power to prolong the narrative and keep and “pandemic bucks” going.

Last Spring, Health Minister Christine Elliott openly admitted that death “with the virus” are being conflated with deaths “from the virus”. The counting system is at best dysfunctional, and at worse, fruadulent. Moreover, Toronto Public Health made a similar admission and nothing came of it.

It really does go past the point of being absent minded. These medical experts have to be deliberately ignoring what is in front of their faces. More likely, they are fully complicit in perpetuating a hoax.

Yaffe seems to offer nothing productive about this “pandemic”, and only pushes continued medical tyranny. She’s never practiced as a doctor (unless it’s well hidden) and just writes papers and lectures at University of Toronto. Nor has she shown any interest in the myriad of legitimate concerns related to human rights violations. She simply acts to give Ford’s Government a cloak of legitimacy.

After all, she just says whatever they write down for her.